UK drugs sector hit by Merck’s scrapped £1bn expansion
A major blow for the uk drugs sector as pharmaceutical giant Merck cancels its planned £1bn research and manufacturing hub expansion in London, citing uncertainty.
A major blow for the uk drugs sector as pharmaceutical giant Merck cancels its planned £1bn research and manufacturing hub expansion in London, citing uncertainty.
Pharmaceutical giant Merck has cancelled its flagship £1b project and is ceasing all R&D operations in the UK, a major blow to the nation’s science sector.